SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001626129-16-000970
Filing Date
2016-11-14
Accepted
2016-11-14 17:28:22
Documents
10
Period of Report
2016-12-16
Effectiveness Date
2016-11-14

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT akrx-def14a_121616.htm DEF 14A 1209757
2 GRAPHIC preproako001.jpg GRAPHIC 4554
3 GRAPHIC preproako002.jpg GRAPHIC 22396
4 GRAPHIC preproako003.jpg GRAPHIC 5170
5 GRAPHIC preproako004.jpg GRAPHIC 988
6 GRAPHIC preproako005.jpg GRAPHIC 171164
7 GRAPHIC preproako006.jpg GRAPHIC 56371
8 GRAPHIC preproako006a.jpg GRAPHIC 5027
9 GRAPHIC preproako007.jpg GRAPHIC 5170
10 GRAPHIC proxycard001.jpg GRAPHIC 8533
  Complete submission text file 0001626129-16-000970.txt   1594704
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32360 | Film No.: 161996073
SIC: 2834 Pharmaceutical Preparations